All In Biotech

Free tool

FAERS Monitor: Inspra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021437 or its brand name (Inspra, Eplerenone). Reports on generic versions are filed under their own applications.

Reports

13,077

Serious

11,339

87% of reports

Hospitalization

6,830

Death reported

1,274

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,162
  • acute kidney injury984
  • cardiac failure969
  • hypotension896
  • fatigue701
  • dizziness688
  • diarrhoea597
  • drug interaction550
  • oedema peripheral537
  • drug ineffective524
  • nausea516
  • off label use502
  • asthenia470
  • atrial fibrillation440
  • fall427

Reports by year received

View as table
YearReports
200441
200556
200663
200772
2008114
2009128
2010148
2011263
2012320
2013272
2014326
2015456
2016553
2017626
2018790
20191,000
20201,212
20211,240
20221,176
20231,045
20241,133
20251,111
2026932

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,082 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cardiac failureSignal96919.618.516,981
acute kidney injurySignal98410.49.88,360
atrial fibrillationSignal4407.36.72,384
hypotensionSignal8967.26.84,812
oedema peripheralSignal5377.16.52,819
drug interactionSignal5505.65.22,078
dyspnoeaSignal1,1623.33.11,915
dizzinessSignal6882.22.1471
fallSignal4272.11.9237
astheniaSignal4702.01.8242
diarrhoea5971.51.498
fatigue7011.41.3101
nausea5161.01.01
off label use5020.90.83
drug ineffective5240.60.6113

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.